These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1847389)

  • 21. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin.
    Sherblom AP; Decker JM; Muchmore AV
    J Biol Chem; 1988 Apr; 263(11):5418-24. PubMed ID: 3356692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tumor necrosis factor on the generation of chlorinated oxidants by adherent human neutrophils.
    Test ST
    J Leukoc Biol; 1991 Aug; 50(2):131-9. PubMed ID: 1649239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human cytokines stimulate neutrophil adherence to IgG autoantibody-treated epithelial basement membranes.
    Gammon WR; Hendrix JD; Mangum K; Jeffes EW
    J Invest Dermatol; 1990 Aug; 95(2):164-71. PubMed ID: 2199582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid purification of recombinant human tumor necrosis factor beta.
    Loh KC; Yao ZJ; Yap MG; Chung MC
    Protein Expr Purif; 1994 Feb; 5(1):70-5. PubMed ID: 8167476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding.
    Hohmann HP; Remy R; Pöschl B; van Loon AP
    J Biol Chem; 1990 Sep; 265(25):15183-8. PubMed ID: 2168404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
    Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
    Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
    Yoshie O; Tada K; Ishida N
    J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factor.
    Fendly BM; Toy KJ; Creasey AA; Vitt CR; Larrick JW; Yamamoto R; Lin LS
    Hybridoma; 1987 Aug; 6(4):359-70. PubMed ID: 2442093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.
    Brekke OL; Espevik T; Bjerve KS
    Lipids; 1994 Feb; 29(2):91-102. PubMed ID: 8152351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M; Simoni P; Antonetti F
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
    Ruggiero V; Latham K; Baglioni C
    J Immunol; 1987 Apr; 138(8):2711-7. PubMed ID: 3031163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
    Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.
    Hass PE; Hotchkiss A; Mohler M; Aggarwal BB
    J Biol Chem; 1985 Oct; 260(22):12214-8. PubMed ID: 2995366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the molecular organization of recombinant human tumor necrosis factor (rTNF) in solution using ethylene glycolbis(succinimidylsuccinate) as the cross-linking reagent.
    Lam KS; Scuderi P; Salmon SE
    J Biol Response Mod; 1988 Jun; 7(3):267-75. PubMed ID: 3392553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
    Espevik T; Brockhaus M; Loetscher H; Nonstad U; Shalaby R
    J Exp Med; 1990 Feb; 171(2):415-26. PubMed ID: 1689365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).
    Goh CR; Loh CS; Porter AG
    Protein Eng; 1991 Oct; 4(7):785-91. PubMed ID: 1665907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.